Taiwan-based startup Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, is experiencing significant growth and positive feedback from healthcare professionals in South Korea. Since launching its app, SugarGenie, in January 2024, the company has witnessed a surge in adoption among healthcare institutions. The company's solution offers data integration, visualization, and personal insights to improve patient care quality and streamline clinical workflows.
While Health2Sync started rolling out its integrated diabetes management solution with Sanofi in hospitals and clinics in South Korea, the company also tapped into the local government's Primary Health Care Chronic Disease Management Programme, which empowers doctors to engage with patients directly. As of December 2024, over 100 healthcare institutions have implemented Health2Sync's Patient Management Platform to enhance the care of patients with diabetes, hypertension, and obesity.
The SugarGenie app captures data from various devices from renowned chronic disease management brands, including Abbott, Sanofi, Omron, Roche, and i-SENS. It allows automatic data synchronization from Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGMs), insulin caps such as SoloSmart, and blood pressure monitors.
Health2Sync has integrated with Eghis Healthcare, a leading Electronic Medical Record (EMR) company serving over 6,000 clinics in South Korea, to streamline clinical workflows. This synchronisation enhances the efficiency and quality of chronic disease management by smoothly embedding Health2Sync's data with existing clinical systems.
